You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Compliance Measurements for Diagnosis of Atherosclerosis
SBC: Engineering Partnership, Ltd Topic: N/AThis project will result in a catheter and associated instrumentation that will use measurements ofof coronary arteries caused by atherosclerotic lesions to diagnose and characterize those lesions. Tinserted into the coronary arteries to a location proximal to the lesion. It will generate low-press1 and 50 kHz to diagnose the lesion. The change in the compliance or distensibility, of the vessel nw ...
SBIR Phase I 1995 Department of Health and Human Services -
SALINE ENHANCED RADIOFREQUENCY ABLATION FOR LIVER TUMORS
SBC: Engineering Partnership, Ltd Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
SALPINGOSONOGRAPH FOR EVALUATION OF FALLOPIAN TUBES
SBC: Engineering Partnership, Ltd Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services -
Accurate and Continuous Measurement of Cardiac Output
SBC: Engineering Partnership, Ltd Topic: N/AN/A
SBIR Phase I 1995 Department of Health and Human Services -
IMMUNOGLOBULIN COATINGS TO PREVENT CATHETER INFECTION
SBC: GAMMA-A TECHNOLOGIES, INC. Topic: N/ACatheters are one of the most commonly used biomaterial implants, (200 million annually in the U.S.). In long term use as for vascular central lines, the urinary tract and peritoneal dialysis, catheters are particularly susceptible to infection. These infections are resistant to antibiotic treatment and persist until removal of the device. Utilizing the concept of Passive Local Immunotherapy, (PL ...
SBIR Phase I 1997 Department of Health and Human Services -
Fish Technology to Localize a Prostate Cancer Gene
SBC: OSCIENT PHARMACEUTICALS CORPORATION Topic: N/AAlthough prostate cancer is the most common malignancy among males in the U.S, little is known abougenes involved in prostate carcinogenesis. Cytogenetic and restriction fragment polymorphism data haof 10q in as many as 30% of prostate cancers. In a collaborative effort with a prostate cancer laborEdward Gelmann (Georgetown Univ.), we have shown that the microsatellite marker D10S187 in 10q25 exhh ...
SBIR Phase I 1995 Department of Health and Human Services -
Isolation of Candidate Genes for Prostate Cancer
SBC: OSCIENT PHARMACEUTICALS CORPORATION Topic: N/AHuman chromosome 10Q24 contains a putative tumor suppressor gene whose inactivation is responsibledevelopment of prostate cancer. The overall goal of this research project is to isolate transcribedchromosomal region to identify candidates for this tumor suppressor gene. Two approaches will be useterminal exon trapping and direct cDNA selection. Both approaches will be applied to large genomic fyea ...
SBIR Phase I 1995 Department of Health and Human Services -
Mapping Human Genomic Regions Identical by Descent
SBC: OSCIENT PHARMACEUTICALS CORPORATION Topic: N/AWe will develop methods that will permit the application of genomic mismatch scanning (GMS) to thegenome. If GMS can be applied to humans, it will rapidly identify the sub-chromosomal locations of cdisorders, such as non-insulin dependent diabetes mellitus, facilitating the subsequent isolation ofuse resources that are currently in house including a hybrid cell line, a set of yeast artificial chDN ...
SBIR Phase I 1995 Department of Health and Human Services -
H PYLORI/HUMAN PROTEIN INTERACTIONS IN GASTRIC CANCER
SBC: OSCIENT PHARMACEUTICALS CORPORATION Topic: N/AThe objective of the proposed work is to perform feasibility studies leading to the development of a novel, new detector for scintigraphy mammography capable of improving the diagnosis of breast cancer and lowering the number of false-positive diagnoses leading to unnecessary invasive biopsies, thereby reducing trauma to the patient while at the same time saving billions of dollars in the national ...
SBIR Phase I 1997 Department of Health and Human Services -
MOLECULAR ANALYSIS OF UNIPARENTAL DISOMY
SBC: OSCIENT PHARMACEUTICALS CORPORATION Topic: N/AN/A
SBIR Phase I 1996 Department of Health and Human Services